ORG Partners LLC lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 45.3% during the 1st quarter, HoldingsChannel reports. The firm owned 1,170 shares of the healthcare conglomerate’s stock after selling 969 shares during the period. ORG Partners LLC’s holdings in UnitedHealth Group were worth $665,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Norges Bank bought a new position in shares of UnitedHealth Group in the 4th quarter worth approximately $6,375,744,000. GAMMA Investing LLC raised its position in UnitedHealth Group by 56,142.1% in the first quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate’s stock worth $4,344,586,000 after acquiring an additional 8,280,404 shares during the period. Raymond James Financial Inc. bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at $1,914,740,000. Amundi increased its stake in shares of UnitedHealth Group by 97.2% in the 4th quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate’s stock worth $3,183,132,000 after purchasing an additional 2,991,470 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in UnitedHealth Group by 36.6% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate’s stock valued at $4,346,712,000 after purchasing an additional 2,301,010 shares during the period. 87.86% of the stock is owned by institutional investors.
Analysts Set New Price Targets
A number of brokerages recently issued reports on UNH. Mizuho cut their price objective on UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating for the company in a research note on Friday, May 16th. Morgan Stanley decreased their price target on UnitedHealth Group from $563.00 to $374.00 and set an “overweight” rating on the stock in a report on Wednesday, May 14th. Robert W. Baird cut UnitedHealth Group from an “outperform” rating to a “neutral” rating and set a $312.00 price target on the stock. in a report on Wednesday, June 11th. HSBC restated a “reduce” rating and set a $270.00 target price (down previously from $490.00) on shares of UnitedHealth Group in a research report on Wednesday, May 21st. Finally, Piper Sandler cut their price objective on UnitedHealth Group from $552.00 to $353.00 and set an “overweight” rating for the company in a research report on Tuesday, June 3rd. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have issued a buy rating to the company. According to data from MarketBeat, UnitedHealth Group has a consensus rating of “Moderate Buy” and an average price target of $426.52.
UnitedHealth Group Stock Down 0.6%
Shares of NYSE UNH opened at $306.90 on Friday. The company has a market cap of $278.40 billion, a P/E ratio of 12.85, a PEG ratio of 1.44 and a beta of 0.44. The firm has a 50-day simple moving average of $365.09 and a two-hundred day simple moving average of $465.88. UnitedHealth Group Incorporated has a 1 year low of $248.88 and a 1 year high of $630.73. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85.
UnitedHealth Group (NYSE:UNH – Get Free Report) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The business had revenue of $109.58 billion during the quarter, compared to analysts’ expectations of $111.56 billion. UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. During the same quarter in the previous year, the business earned $6.91 EPS. Research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 24th. Investors of record on Monday, June 16th will be issued a $2.21 dividend. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.10. The ex-dividend date of this dividend is Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.88%. UnitedHealth Group’s payout ratio is presently 37.02%.
Insiders Place Their Bets
In related news, CEO Stephen J. Hemsley bought 86,700 shares of the stock in a transaction on Friday, May 16th. The stock was bought at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the completion of the acquisition, the chief executive officer now directly owns 679,493 shares in the company, valued at approximately $196,081,295.01. This represents a 14.63% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Kristen Gil purchased 3,700 shares of UnitedHealth Group stock in a transaction dated Thursday, May 15th. The stock was bought at an average cost of $271.17 per share, with a total value of $1,003,329.00. Following the completion of the transaction, the director now owns 3,818 shares in the company, valued at approximately $1,035,327.06. This represents a 3,135.59% increase in their position. The disclosure for this purchase can be found here. Insiders have bought 109,408 shares of company stock worth $31,607,768 in the last ninety days. 0.28% of the stock is owned by company insiders.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles
- Five stocks we like better than UnitedHealth Group
- What does consumer price index measure?
- Robinhood Director Sells Millions, But HOOD Stock Eyes Gains
- Energy and Oil Stocks Explained
- Coinbase Stock Pops as Senate Passes GENIUS Stablecoin Bill
- Investing in Commodities: What Are They? How to Invest in Them
- Super Micro Computer Stock’s Rally Backed by Strong Financials
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.